Public Joint Stock Co Pharmstandard - Net Worth and Insider Trading

Public Joint Stock Co Pharmstandard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Public Joint Stock Co Pharmstandard owns 2 companies in total, including Argos Therapeutics Inc (ARGSQ) , and Protara Therapeutics Inc (TARA) .

Click here to see the complete history of Public Joint Stock Co Pharmstandard’s form 4 insider trades.

Insider Ownership Summary of Public Joint Stock Co Pharmstandard

Ticker	Comapny	Transaction Date	Type of Owner
ARGSQ	Argos Therapeutics Inc	2017-10-31	10 percent owner
TARA	Protara Therapeutics Inc	2014-10-21	10 percent owner

Public Joint Stock Co Pharmstandard Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Public Joint Stock Co Pharmstandard Ownership Network

Ownership Network List of Public Joint Stock Co Pharmstandard

No Data

Ownership Network Relation of Public Joint Stock Co Pharmstandard

Public Joint Stock Co Pharmstandard Owned Company Details

What does Argos Therapeutics Inc do?

Who are the key executives at Argos Therapeutics Inc?

Public Joint Stock Co Pharmstandard is the 10 percent owner of Argos Therapeutics Inc. Other key executives at Argos Therapeutics Inc include Vice President and CFO Richard D Katz , 10 percent owner Pharmstandard International S.a. , and Chief Medical Officer Allen Lee F Md Phd .

Argos Therapeutics Inc (ARGSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Argos Therapeutics Inc (ARGSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Argos Therapeutics Inc (ARGSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Argos Therapeutics Inc (ARGSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Argos Therapeutics Inc Insider Transactions

No Available Data

Public Joint Stock Co Pharmstandard Mailing Address

Above is the net worth, insider trading, and ownership report for Public Joint Stock Co Pharmstandard. You might contact Public Joint Stock Co Pharmstandard via mailing address: Likhachevsky Drive, 5 "b", Dolgoprudny 1z 141701.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.